- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05879679
Pilot Study on the Validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa (BN) and Binge Eating Disorders (BED) (MetaBou)
Craving is defined as an irrepressible urge to consume certain products and represents one of the key factors in severe substance use disorders, as illustrated by its recent inclusion as a diagnostic criterion in the most recent fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM 5). However, the pathophysiological models of craving remain debated.
The "metacognitive hub model", a conceptual, experimental and clinical approach to craving, proposes that craving should be considered as the embedded consequence of the interaction between three components (the reflexive, automatic and interoceptive systems), each of which has an implicit and explicit element. This model links the three components by suggesting that metacognitive abilities, the ability to understand one's own cognitive functioning, may be a skill of individuals that allows them to make the three sub-components explicit or not.
To date, the conception of eating disorders is increasingly similar to that of addictive disorders. Indeed, there is growing evidence that the symptomatology of bulimia nervosa and binge eating disorder can be considered in part as an "food addiction" and would fit the diagnostic criteria of an addictive disorder. Bulimia nervosa is an eating disorder (DSM 5) characterized by a cycle of binge eating and compensatory behaviors such as self-induced vomiting that tend to negate or compensate for the effects of the binge eating. Binge eating disorder (DSM 5) is characterized by a cycle of binge eating, but without the compensatory behaviors seen in bulimia nervosa. In addition, there are common neurological aspects as well as similar cognitions between these eating disorders and addictive disorders. Given the importance of craving in addictive pathology, it seems essential to address this issue in bulimia nervosa and binge eating disorder. The cognitive difficulties of patients with bulimia nervosa and binge eating disorder, which are close to the difficulties observed in patients with addictive behaviors, suggest that the "metacognitive hub model" could provide a clear and measurable theoretical framework of the different dimensions of craving.
The overall objective of this project is to explore the relationship between the level of craving induced by food picture exposure and the level of impairment of the reflexive, automatic, interoceptive, and metacognitive systems in women with bulimia nervosa and binge eating disorder and to compare these impairments according to the nature of the eating disorder (i.e., binge eating versus bulimia nervosa).
Our hypotheses are:
- the induction of food craving will affect the reflexive, automatic, and interoceptive systems of patients with bulimia nervosa and binge eating disorder.
- the magnitude of the effect of food craving induction on implicit craving and explicit craving will be modulated by the participants' metacognitive abilities.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Gabrielle Hudon, Msc
- Phone Number: 8015 +14186568711
- Email: equipe.iceta@criucpq.ulaval.ca
Study Locations
-
-
-
Québec, Canada
- Not yet recruiting
- Centre d'expertise Poids, Image et Alimentation (CEPIA)
-
Contact:
- Catherine Bégin, PhD
-
Québec, Canada
- Recruiting
- IUCPQ
-
Contact:
- sylvain Iceta
-
-
-
-
-
Nantes, France
- Not yet recruiting
- Université de Nantes
-
Contact:
- Valentin Flaudias, Psy, PhD
-
Principal Investigator:
- Valentin Flaudias, Pdy, PhD
-
Sub-Investigator:
- Aurelien Cornil, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Participants consulted by specialized psychiatrist at IUCPQ Participants who have already participated in a research project and have agreed to be contacted for other projects Participants recruited via the ANEB and Maison l'Éclaircie mailing lists and via an ad on social networks.
Participants receiving care at the CEPIA or on the CEPIA waiting list.
Description
Inclusion Criteria:
- have been medically diagnosed with binge eating disorder or bulimia nervosa
- fluent in french
- able to consent
Exclusion Criteria:
- co-morbid substance use disorder,
- pregnancy or breastfeeding
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Binge Eating Disorder
Participants with a binge eating disorder (DSM-5 criteria)
|
Standardized craving induction procedure will be used, based on exposure to food-related images (https://www.lippc2s.fr/food-cal-pictures/). Craving intensity will be measured by visual analogic scale before and after the induction sequence.
|
|
Bulimia Nervosa
Participants with a bulimia nervosa (DSM-5 criteria)
|
Standardized craving induction procedure will be used, based on exposure to food-related images (https://www.lippc2s.fr/food-cal-pictures/). Craving intensity will be measured by visual analogic scale before and after the induction sequence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attention Network Test (ANT)
Time Frame: 1 hour (after food craving induction)
|
The ANT is a task designed to test three attentional networks in children and adults: alerting, orienting, and executive control
|
1 hour (after food craving induction)
|
|
Dot Probe Task
Time Frame: 1 hour (after food craving induction)
|
To test and measure selective attention
|
1 hour (after food craving induction)
|
|
Water load task
Time Frame: 1 hour (after food craving induction)
|
This task was originally developed to induce gastric distension and assess gastrointestinal symptoms in patients with functional digestive disorders.
This task stimulates the stomach using a natural distension stimulus (i.e., water ingestion) and without the complex hormonal response of a caloric meal.
|
1 hour (after food craving induction)
|
|
Live metacognition
Time Frame: 1 hour (after food craving induction)
|
"live" metacognitive assessment will be done by asking the participants to rate their level of confidence on a visual analog scale ranging from 0% (I just guessed) to 100% (completely confident) for each items.
|
1 hour (after food craving induction)
|
|
Avoidance/Approach task adapted for food craving
Time Frame: 1 hour (after food craving induction)
|
In this task, participants are asked to move a joystick that simulates the movement of the food represented in the image.
The joystick movements are accompanied by a zoom effect that increases the illusion of movement.
|
1 hour (after food craving induction)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Depression Inventory II (BDI-II)
Time Frame: Baseline
|
Minimum score : 0; Maximun score : 63; Higher scores mean a worse outcome.
|
Baseline
|
|
State-Trait Anxiety Inventory (STAI)
Time Frame: Baseline
|
The questionnaire includes two scales (20 items) consisting of a total of 40 questions.
For each scale the minimum score is 0 and the maximun score is 80.
Higher scores mean a worse outcome.
|
Baseline
|
|
Eating Disorder Examination Questionnaire (EDE-Q)
Time Frame: Baseline
|
The measure provides four attitudinal subscale scores: Restraint (5 items), Eating Concern (5 items), Shape Concern (8 items), and Weight Concern (5 items).
An overall Global score is the mean of the four subscale scores.
Responses are on a 7-point ordinal response; minimum score : 0, maximun score: 6; higher scores mean a worse outcome.
|
Baseline
|
|
Food Craving Questionnaire State (FCQ-S)
Time Frame: Baseline
|
Minimum : 15; Maximun : 75; Higher scores mean a worse outcome.
|
Baseline
|
|
Food Craving Questionnaire Trait (FCQ-T)
Time Frame: Baseline
|
Minimum : 39; Maximun : 234; Higher scores mean a worse outcome.
|
Baseline
|
|
Visual Analogic Scale of craving
Time Frame: Baseline, at 1 hour (after craving induction), at 3 hours (end of the session_
|
It represents a continuous visual progression of craving from one extreme to another, from "no craving at all" to "extreme and uncontrollable craving," with patients stating the intensity of their current craving between these two extremes.
|
Baseline, at 1 hour (after craving induction), at 3 hours (end of the session_
|
|
Schedule for the Assessment of Insight in Eating Disorders (SAI-ED)
Time Frame: Baseline
|
Interview-based scale for the multidimensional assessment of insight in eating disorders.
It includes three categories: illness awareness, symptom awareness, and treatment engagement.
Minimum score : 0, maximun score: 29; Higher scores mean a better outcome.
|
Baseline
|
|
Difficulties in Emotional Regulation Scale (DERS- 18)
Time Frame: Baseline
|
Minimum score : 18, maximun score : 90; Higher scores mean a worse outcome.
|
Baseline
|
|
Attentional Control Scale (ACS)
Time Frame: Baseline
|
Minimum score : 20, maximun score : 80; Higher scores mean a better outcome.
|
Baseline
|
|
Body Awareness Questionnaire (BAQ)
Time Frame: Baseline
|
Minimum score: 18; Maximun score: 126; Higher scores mean a better outcome.
|
Baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height
Time Frame: Baseline
|
Baseline
|
|
|
Weight
Time Frame: Baseline
|
Baseline
|
|
|
Gender
Time Frame: Baseline
|
Baseline
|
|
|
Age
Time Frame: Baseline
|
Baseline
|
|
|
Biological sex
Time Frame: Baseline
|
Baseline
|
|
|
Body Mass Index (BMI)
Time Frame: Baseline
|
Weight / Height2
|
Baseline
|
|
Waist and hips circumferences
Time Frame: Baseline
|
in cm
|
Baseline
|
|
Menopausal status or contraception
Time Frame: Baseline
|
Baseline
|
|
|
Socio-professional category
Time Frame: Baseline
|
Number of participants per socioprofessional category as defined by statistic canada
|
Baseline
|
|
Medical history and concomitant treatment
Time Frame: Baseline
|
Rates of various associated diseases (e.g., cardiovascular, digestive disorders).
Type of medications (antidepressants, antipsychotics, hypotensive drugs) and their rates.
|
Baseline
|
|
Ethnic origin
Time Frame: Baseline
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sylvain Iceta, MD, PhD, Fondation IUCPQ
- Study Chair: Valentin Flaudias, Psy, PhD, Université de Nantes
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-4019, 22336
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Binge-Eating Disorder
-
University of Sao Paulo General HospitalActive, not recruitingBinge Eating DisorderBrazil
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
-
ShireCompleted
-
Lindner Center of HOPEUniversity of CincinnatiCompleted
-
Axsome Therapeutics, Inc.Enrolling by invitationBinge-Eating DisorderUnited States
-
BioprojetCompleted
-
Sao Jose do Rio Preto Medical SchoolFundação de Amparo à Pesquisa do Estado de São PauloCompletedBinge-Eating Disorder | Eating Disorders | Eating Behavior | Eating Disorder | Binge Eating Disorder Associated With ObesityBrazil
-
Axsome Therapeutics, Inc.RecruitingBinge-Eating DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBinge-Eating DisorderUnited States
-
Ali RezaiActive, not recruiting
Clinical Trials on Food craving induction
-
Rennes University HospitalWithdrawnAlcohol Dependence | AlcoholismFrance
-
Kaiser PermanenteNational Institute on Drug Abuse (NIDA)RecruitingAlcohol Drinking | Cannabis UseUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Beijing Normal UniversityCompleted
-
University of WyomingAmerican Diabetes AssociationActive, not recruitingDiet Modification | Obesity and Type 2 DiabetesUnited States
-
Washington University School of MedicineCompleted
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH); Mount Zion...Completed
-
Beijing Normal UniversityCompletedInternet Gaming Disorder | Emotion RegulationChina
-
University of Toronto Practice Based Research NetworkCompletedHypertension | Type 2 DiabetesCanada
-
Memorial Sloan Kettering Cancer CenterRecruitingCushing Syndrome | Cushing's Disease | Cushing DiseaseUnited States